Enhancing immunogenic responses through CDK4/6 and HIF2α inhibition in Merkel cell carcinoma
Open Access
- 10 December 2023
- Vol. 10 (1) , e23521
Abstract
No abstract availableKeywords
Funding Information
- Elsa U. Pardee Foundation
- University of Washington
- National Institutes of Health (P01CA225517)
This publication has 79 references indexed in Scilit:
- High-Affinity Rb Binding, p53 Inhibition, Subcellular Localization, and Transformation by Wild-Type or Tumor-Derived Shortened Merkel Cell Polyomavirus Large T AntigensJournal of Virology, 2014
- Long Noncoding RNAs: Past, Present, and FutureGenetics, 2013
- The Cystine/Glutamate Antiporter System x c − in Health and Disease: From Molecular Mechanisms to Novel Therapeutic OpportunitiesAntioxidants & Redox Signaling, 2013
- Merkel cell polyomavirus: A newly discovered human virus with oncogenic potentialVirology, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Hypoxia. Cross talk between oxygen sensing and the cell cycle machineryAmerican Journal of Physiology-Cell Physiology, 2011
- Detection of Merkel cell polyomavirus (MCPyV) in Merkel cell carcinoma cell lines: Cell morphology and growth phenotype do not reflect presence of the virusInternational Journal of Cancer, 2009
- Cell cycle, CDKs and cancer: a changing paradigmNature Reviews Cancer, 2009
- G1 cell-cycle control and cancerNature, 2004
- CYCLIN-DEPENDENT KINASES: Engines, Clocks, and MicroprocessorsAnnual Review of Cell and Developmental Biology, 1997